XTAE
AYAL
Market cap1.20bUSD
Jul 10, Last price
12,690.00ILS
Name
Ayalon Insurance Company Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating through its subsidiaries in Israel, Ayalon Insurance Company Ltd offers a comprehensive range of insurance products. Their health coverage extends to nursing care, medical expenses, surgical procedures and organ transplants, dental services, personal accident protection, travel insurance, and medical policies specifically for foreign workers. The company also provides property and liability insurance, including home documentation, third-party and employer liability, general property protection, vehicle coverage, and professional indemnity. Beyond traditional insurance, Ayalon also offers financial products such as savings plans, pension schemes, and provident funds. Additional specialized policies cover automobiles, residential properties, critical illnesses, life assurance, mortgages, businesses, directors and officers, engineering projects, and agriculture. They also provide reverse mortgage solutions and tailored insurance for collectives and organizations. Customers access these services via a broad network of agents and agencies. Founded in 1976 and based in Ramat Gan, Israel, the firm was formerly known as Ayalon Holdings Ltd, rebranding to its current name in July 2022. Ayalon Insurance Company Ltd is a subsidiary of Wesure Global Tech Ltd.
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||